Ganglion Cysts  >>  Inbrija (levodopa inhalation powder)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inbrija (levodopa inhalation powder) / Acorda
NCT01777555 / 2012-005822-31: Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes

Checkmark CVT 301-003 study in PD
Jun 2017 - Jun 2017: CVT 301-003 study in PD
Checkmark
Apr 2016 - Apr 2016: 
Checkmark
More
Completed
2b
89
US, Europe, RoW
CVT-301, Levodopa Inhalation Powder, Placebo
Acorda Therapeutics
Idiopathic Parkinson's Disease
01/14
01/14
NCT01617135 / 2012-000181-37: Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Checkmark MDS 2015
Aug 2015 - Aug 2015: MDS 2015
Checkmark
Jun 2014 - Jun 2014: 
Completed
2
25
Europe, RoW
CVT-301, Placebo, Sinemet (carbidopa/levodopa)
Acorda Therapeutics, Michael J. Fox Foundation for Parkinson's Research
Idiopathic Parkinson's Disease
11/12
12/12

Download Options